Canavan disease (CD) is a neurodegenerative disease, caused by a deficiency in the enzyme aspartoacylase (ASPA). This enzyme has been localized to oligodendrocytes; however, it is still undefined how ASPA deficiency affects oligodendrocyte development. In normal mice the pattern of ASPA expression coincides with oligodendrocyte maturation. Therefore, postnatal oligodendrocyte maturation was analyzed in ASPAdeficient mice (CD mice). Early in development, CD mice brains showed decreased expression of neural cell markers that was later compensated. In addition, the levels of myelin proteins were decreased along with abnormal myelination in CD mice compared to wild-type (WT). These defects were associated with increased global levels of acetylated histone H3, decreased chromatin compaction and increased GFAP protein, a marker for astrogliosis. Together, these findings strongly suggest that, early in postnatal development, ASPA deficiency affects oligodendrocyte maturation and myelination.
Introduction
Canavan disease (CD) is a devastating neurodegenerative disease, characterized by developmental delays and mental retardation (Matalon et al., 1995) . CD patients display degeneration of the white matter, demyelination and, as shown by histological analysis, a spongy brain appearance. These effects are caused by a recessive mutation in the aspartoacylase (ASPA)-encoding gene (Adachi et al., 1973; Matalon et al., 1988; de Coo et al., 1991) . ASPA is an enzyme reported to be involved in the hydrolysis of N-acetyl-aspartate (NAA) into acetate and aspartate (Kaul et al., 1991; Moffett et al., 2007) . CD is therefore characterized by a dramatic increase in NAA levels and a decrease in the products acetate and aspartate (Hagenfeldt et al., 1987; Bluml, 1999; Kumar et al., 2006) . Early observations suggested an association of CD with oligodendrocytes due to loss of white matter as a result of the absence of functional ASPA (Kaul et al., 1991) . ASPA mRNA was localized to the white matter of postnatal rats (Kirmani et al., 2003) and mice (Kumar et al., 2009 ), in oligodendrocytes (Baslow, 1999 Bhakoo and Pearce, 2000; Bhakoo et al., 2001; Kirmani et al., 2003; Klugmann et al., 2003; Madhavarao et al., 2004) , and also in purified myelin (Wang et al., 2007) , thereby suggesting the potential involvement of ASPA in oligodendrocyte development. Furthermore, numerous studies have implicated the role of hydrolyzed NAA in supplying acetyl groups for lipid synthesis, an important component of myelin (D'Adamo et al., 1968; Burri et al., 1991; Miller, 1996; Chakraborty et al., 2001) . It is believed that NAA plays an important role and serves as a type of neuronal support in myelin formation (Chakraborty and Ledeen, 2003; Wang et al., 2009 ). In addition, a decrease in the synthesis of myelin-associated lipids and reduced acetate levels have been reported during myelination in CD mice (Madhavarao et al., 2005) , suggestive of altered lipid synthesis (Ledeen et al., 2006; Namboodiri et al., 2006) , and of a significant role of ASPA in oligodendrocyte maturation. Besides the role in myelin formation and function, acetylation also modulates the function of nucleosomal histones, chromatin components that have been shown to play a critical role in the expression of genes important for oligodendrocyte maturation (Liu and Casaccia, 2010) . Based on these premises, we hypothesized that ASPA could play a critical role in oligodendrocyte development and contribute to CD pathophysiology. 
